Director Maher Bill purchased 809 JEQ shares for $4,991.53 on 2024-08-23, raising holdings 31.6% to 3,367 shares.
On 2024-08-23, director Maher Bill purchased 809 shares at $6.17, expanding his JEQ stake by 31.6% to 3,367 shares post-transaction. This is his second discretionary purchase at JEQ in nine days (prior buy on 2024-08-14), suggesting continued accumulation in the fund. Historically, his cross-ticker track record shows 11 prior buys with an 80.00% 90-day win rate and +0.7% average 90-day return, but his same-ticker purchase history at JEQ is mixed: the 2023-07-10 buy delivered -9.4% over 90 days, and 0 of 1 measurable prior JEQ buys achieved positive 90-day returns. Stock price is currently at $6.12, down 3.5% from its 52-week high and up 4.1% over 30 days, placing the trade near recent highs but not at depressed levels.
Director Maher Bill purchases 650 shares of HQL at $15.37; holdings rise 61.0% to 1,715 shares
Director Maher Bill increased his stake in abrdn Life Sciences Investors (HQL) by purchasing 650 shares at $15.37 on 2024-08-23, expanding his total holdings by 61.0% from 1,065 to 1,715 shares. His prior buy at this ticker on 2023-12-28 realized a 90-day return of +0.6%, and that trade's timing pattern (90d return positive) indicates it was well-timed. Across his cross-ticker track record, he has made 11 prior buys with an 80.00% 90-day win rate and average 90-day return of +0.7%, though current market conditions show HQL down 3.6% from its 52-week high and -1.3% over the past 30 days. The significance of this buy is moderate: while it reflects continued accumulation in the same security and demonstrates a track record of positive longer-term outcomes on average, the recent price momentum is mixed and current valuation remains near mid-range within the 52-week band.
Director Maher Bill buys 931 shares of AEF at $5.37 on 2024-08-23, adding to 14,962 post-transaction holdings.
Director Maher Bill purchased 931 shares of ABRDN Emerging Markets Equity Income Fund at $5.37, bringing his total holdings to 14,962 shares, a 6.6% increase from his prior position. This represents his second purchase at AEF within 9 days—he bought again on 2024-08-14—suggesting sequential accumulation in the fund. The current price of $5.37 is -2.0% from the 52-week high and the stock has moved +3.9% over the last 30 days, placing this purchase in the context of modest recent upward momentum. Across his cross-ticker open-market history, the insider's 11 prior buys averaged -0.2% return at 30 days and +0.7% at 90 days with an 80% win rate, though his prior AEF purchase outcome is not yet measurable.
Director Maher Bill purchased 2,000 shares of abrdn National Municipal Income Fund (VFL) at $10.99, raising stake to 3,028 shares (+194.4%).
Maher Bill increased his holding in VFL by 2,000 shares on 2024-08-14 for $21,980.00, more than doubling his position from 1,028 to 3,028 shares. His prior buy at this ticker on 2023-12-28 produced a +1.0% 90-day return, consistent with his cross-ticker track record showing an 80% win rate over 90 days with a +0.7% average return. The current price of $11.11 stands at the 52-week high, and the stock has appreciated 5.1% in the past 30 days and 7.4% over 90 days, placing this purchase near the peak of recent range activity. The timing and magnitude of this purchase warrant attention in the context of the fund's recent price momentum and the director's demonstrated historical accuracy with similar accumulations.
Director Maher Bill purchases 1,000 shares of abrdn World Healthcare Fund (THW) at $13.03
Maher Bill, a Director, purchased 1,000 shares of abrdn World Healthcare Fund at $13.03 on 2024-08-14, establishing a new position in the fund with total value of $13,030.00. This marks his first acquisition of this fund asset. The purchase price of $13.03 is below the current price of $13.16, and sits approximately -4.5% from the 52-week high, placing it in a modest discount context. While his cross-ticker track record shows an 80.00% win rate on 90-day returns across 8 prior buys with an average 90d return of +0.7%, this particular transaction represents an initial position rather than an accumulation pattern, and lacks same-ticker history to contextualize the decision's significance at this specific fund.
Director Maher Bill bought 1,000 shares of JEQ at $5.90 on 2024-08-14, expanding holdings 64.2% to 2.6K shares.
Maher Bill purchased 1,000 shares at $5.90, bringing his total holdings to 2,558 shares—a 64.2% increase from the prior 1,558 shares. The current price of $6.02 is 5.0% below the 52-week high of $6.34 and down 2.8% over the past 30 days. His cross-ticker track record shows 8 prior open-market buys with an 80.00% 90-day win rate and average 90-day return of +0.7%. However, his sole prior purchase at JEQ on 2023-07-10 underperformed materially, posting a 90-day return of -9.4%, indicating weaker execution at this specific security. This transaction represents a material accumulation at a ticker where the insider's historical timing has not been favorable.
Director Maher Bill purchases 1,000 shares of AEF at $5.25; holdings rise to 14,031 shares.
Maher Bill, a Director, purchased 1,000 shares of ABRDN EMERGING MARKETS EQUITY INCOME FUND, INC. (AEF) at $5.25 on 2024-08-14, increasing his holdings from 13,031 shares to 14,031 shares, a 7.7% increase. The purchase price of $5.25 is modestly below the current price of $5.40 and near the lower end of the 52-week range of $4.42–$5.48. His broader cross-ticker track record shows 8 prior buys with an 80.00% 90-day win rate and average 90-day return of +0.7%, indicating a modest historical pattern of disciplined accumulation that has more often than not captured near-term upside. The transaction itself is routine in scale and timing but adds to a documented history of selective equity purchases.
